[go: up one dir, main page]

FR2321291A1 - Nouveaux derives de l'amino-4 quinoleine, leur preparation et leurs applications therapeutiques - Google Patents

Nouveaux derives de l'amino-4 quinoleine, leur preparation et leurs applications therapeutiques

Info

Publication number
FR2321291A1
FR2321291A1 FR7624952A FR7624952A FR2321291A1 FR 2321291 A1 FR2321291 A1 FR 2321291A1 FR 7624952 A FR7624952 A FR 7624952A FR 7624952 A FR7624952 A FR 7624952A FR 2321291 A1 FR2321291 A1 FR 2321291A1
Authority
FR
France
Prior art keywords
quinoleine
amino
preparation
therapeutic applications
new derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7624952A
Other languages
English (en)
Other versions
FR2321291B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SERDEX SAS
Original Assignee
SERDEX SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SERDEX SAS filed Critical SERDEX SAS
Publication of FR2321291A1 publication Critical patent/FR2321291A1/fr
Application granted granted Critical
Publication of FR2321291B1 publication Critical patent/FR2321291B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7624952A 1975-08-18 1976-08-17 Nouveaux derives de l'amino-4 quinoleine, leur preparation et leurs applications therapeutiques Granted FR2321291A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3424375A GB1496371A (en) 1975-08-18 1975-08-18 4-amino-quinoline derivatives process for their preparation and therapeutic applications thereof

Publications (2)

Publication Number Publication Date
FR2321291A1 true FR2321291A1 (fr) 1977-03-18
FR2321291B1 FR2321291B1 (fr) 1978-12-22

Family

ID=10363223

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7624952A Granted FR2321291A1 (fr) 1975-08-18 1976-08-17 Nouveaux derives de l'amino-4 quinoleine, leur preparation et leurs applications therapeutiques

Country Status (4)

Country Link
BE (1) BE845271A (fr)
ES (1) ES450995A1 (fr)
FR (1) FR2321291A1 (fr)
GB (1) GB1496371A (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0387821A3 (fr) * 1989-03-17 1991-09-18 BASF Aktiengesellschaft 2-Alkyl-4-arylméthylaminoquinoléines, leur utilisation et médicaments les contenant
WO1993003030A1 (fr) * 1991-08-02 1993-02-18 Pfizer Inc. Derives de quinoline utilises comme immunostimulants____________
US5985919A (en) * 1995-05-09 1999-11-16 Basf Aktiengesellschaft (Het)aryloxy-, -thio- , aminocrotonates, methods of preparing them and their use as insecticides and fungicides
US20120264810A1 (en) * 2009-09-22 2012-10-18 The University Of British Columbia Compositions and methods for enhancing cellular uptake and intracellular delivery of lipid particles

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3644825A1 (de) * 1986-12-31 1988-07-14 Basf Ag Substituierte 1,8-naphthyridin-derivate und diese enthaltende fungizide
IL89029A (en) * 1988-01-29 1993-01-31 Lilly Co Eli Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them
GT198900008A (es) * 1988-01-29 1990-07-17 Derivados de quinolina, quinazolina y cinolina.
ES2201674T3 (es) * 1998-01-26 2004-03-16 Smithkline Beecham Plc Derivados de quinolina con propiedades antibacterianas.
GB9822450D0 (en) * 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
GB9914486D0 (en) 1999-06-21 1999-08-18 Smithkline Beecham Plc Medicaments
GB9917406D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
US20060074105A1 (en) * 2004-09-20 2006-04-06 Serenex, Inc. Substituted quinoline and quinazoline inhibitors of quinone reductase 2
KR102205202B1 (ko) 2013-02-01 2021-01-21 웰스태트 테러퓨틱스 코포레이션 항염증, 항진균, 항기생충, 및 항암 활성을 갖는 아민 화합물

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH58A (de) * 1889-01-08 F Bachschmid Neuerung an Ankerhemmungen
CH84A (fr) * 1889-01-10 Fontainemelon Horlogerie Perfectionnement apporté dans la construction des mécanismes de remontoir des montres de tous calibres
CH49A (fr) * 1889-01-16 Allemand H E Système de canons-olives à rivure intérieure
CH72A (de) * 1889-01-17 G Jun Meguin Neuerung an Kämmmaschinen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH58A (de) * 1889-01-08 F Bachschmid Neuerung an Ankerhemmungen
CH84A (fr) * 1889-01-10 Fontainemelon Horlogerie Perfectionnement apporté dans la construction des mécanismes de remontoir des montres de tous calibres
CH49A (fr) * 1889-01-16 Allemand H E Système de canons-olives à rivure intérieure
CH72A (de) * 1889-01-17 G Jun Meguin Neuerung an Kämmmaschinen

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
100064B 1976 ) *
3967E 1955 *
55356N 1970 *
8254C 1963 *
COMPTES RENDUS DE L ACADEMIE DES SCIENCES, 282, SERIE D 509-11 1976 *
JOURNAL OF THE CHEMICAL SOCIETY, 1957, 4403-4 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0387821A3 (fr) * 1989-03-17 1991-09-18 BASF Aktiengesellschaft 2-Alkyl-4-arylméthylaminoquinoléines, leur utilisation et médicaments les contenant
WO1993003030A1 (fr) * 1991-08-02 1993-02-18 Pfizer Inc. Derives de quinoline utilises comme immunostimulants____________
JPH06504294A (ja) * 1991-08-02 1994-05-19 ファイザー・インコーポレーテッド 免疫刺激剤としてのキノリン誘導体
US5506235A (en) * 1991-08-02 1996-04-09 Pfizer Inc. Quinoline derivatives as immunostimulants
US5985919A (en) * 1995-05-09 1999-11-16 Basf Aktiengesellschaft (Het)aryloxy-, -thio- , aminocrotonates, methods of preparing them and their use as insecticides and fungicides
US20120264810A1 (en) * 2009-09-22 2012-10-18 The University Of British Columbia Compositions and methods for enhancing cellular uptake and intracellular delivery of lipid particles

Also Published As

Publication number Publication date
BE845271A (fr) 1977-02-18
GB1496371A (en) 1977-12-30
ES450995A1 (es) 1977-09-01
FR2321291B1 (fr) 1978-12-22

Similar Documents

Publication Publication Date Title
BE789629A (fr) Nouveaux derives de la pleuromutiline, leur preparation et leurapplication en therapeutique
BE838509A (fr) Nouveaux derives de l'isoxazole, leur preparation et leur application comme medicaments
BE849196A (fr) Derives de l'argininamide, leur preparation et leurs utilisation therapeutiques
FR2336135A1 (fr) Nouveaux derives de l'ergoline, leur preparation et leur application comme medicaments
BE842883A (fr) Nouveaux composes de rifamycine et leurs applications en therapeutique
BE845271A (fr) Nouveaux derives de l'amino-4 quinoleine, leur preparation et leurs applications therapeutiques
FR2333511A1 (fr) Nouveaux derives de dihydro-3,4 quinazoline et leurs procedes de preparation
BE868882A (fr) Derives halogenomethyles d'alpha-aminoacides, leur preparation et leurs utilisations therapeutiques
FR2345150A2 (fr) Nouveaux derives de la thienopyridine, et leur application
BE843679A (fr) Derives de 16,16-spirocycloalkylprostaglandines, leur preparation et leurs utilisations therapeutiques
BE856782A (fr) Nouveaux derives de l'isoxazolo (4,5-c) pyridine, leur preparation et leur application comme medicaments
BE839967R (fr) Nouveaux derives de l'isoquinoleine, leur preparation et leur application comme medicaments
FR2330404A1 (fr) Derives de la 1,4-diazepine, leur preparation et leurs utilisations therapeutiques
FR2323691A1 (fr) Nouveaux derives de 1,2-benzisoxazole et leur preparation
FR2320090A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2330400A1 (fr) Derives d'acides pyrimidine-7-carboxyliques substitues, leur preparation et leurs utilisations therapeutiques
FR2308365A2 (fr) Derives de l'hydroxy-9 ellipticine et leur application therapeutique
FR2314723A1 (fr) Nouveaux derives du benzo-cyclohepta-thiophene, leur preparation et leur application en therapeutique
BE839969A (fr) Nouveaux derives de l'isoquinoleine, leur preparation et leur application comme medicaments
BE819088A (fr) Nouveaux derives d'aminopyrrole et leur preparation
BE861502R (fr) Nouveaux derives d'isoxazoles, leur procde de preparation et leurs applications
BE786432A (fr) Nouveaux derives de l'acide 4-chloro-5-sulfamoyl-antranilique, leur preparation et leurs applications
FR2326180A1 (fr) Derives d'acide oxanilique et leur preparation
FR2378004B2 (fr) Derives de l'argininamide, leur preparation et leurs utilisations therapeutiques
FR2291205A1 (fr) Nouveaux derives de 7 a-alcoxycephalosporine et leur preparation

Legal Events

Date Code Title Description
ST Notification of lapse